Corteva, Inc.CTVA
NYSE•Basic Materials•Agricultural Inputs
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Corteva, Inc. (CTVA) reported trailing twelve months revenue of $17.89B as of March 2026, a 6.3% increase year-over-year. Quarterly revenue reached $4.91B, reflecting continued top-line momentum.
Corteva, Inc. generated $1.16B in TTM net income, with quarterly EBITDA of $1.27B. The operating margin expanded from 17.4% to 19.9%, suggesting improving cost efficiency and pricing discipline.
The spread between operating margin (19.9%) and net margin (14.7%) indicates moderate non-operating costs. Net margin has narrowed from 14.8% a year ago, reflecting increased costs or interest expense.
CTVA trades at a P/E of 48.0x (a premium multiple) and a P/S of 3.1x. The price-to-book ratio of 2.3x reflects a moderate premium to book value.
The company reported negative free cash flow of $-2.97B, indicating cash consumption over the period. The balance sheet shows $42.72B in total assets with $1.68B in long-term debt against $24.36B in stockholders equity for a debt-to-equity ratio of 0.1, a conservative capital structure. Data based on the most recent quarterly reports.
Competitive analysis based on 21 quarters of fundamental data
Operating margins are under pressure, averaging 7.1%. The business may lack pricing power or face rising costs.'
ROE is positive at ~4.5% on average, adequate but below the threshold typically associated with wide moats.
5 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Revenue shows resilience with 4 of 7 quarters posting growth — demand is generally stable but has seen some soft patches.
Data-driven red flags and warnings across 21 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF consistently trails net income (avg -13.9x) — earnings may be inflated by non-cash items or aggressive accounting.
D/E ratio is 0.1 — conservative capital structure with low financial risk.
Revenue is stable or growing over recent quarters — demand appears durable.
FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.
Shares decreased 3.4% — net buybacks are reducing shares outstanding and boosting per-share value.
Quarterly standardized metrics.
Stock price and market valuation
Revenue and earnings growth across quarters
Assets, cash, debt, and leverage
Price multiples and return ratios
Operating efficiency and return metrics
Free cash flow, earnings quality, and capital allocation